{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:39:30Z","timestamp":1768811970098,"version":"3.49.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T00:00:00Z","timestamp":1659225600000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004897","name":"Pennsylvania Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01 EY029223"],"award-info":[{"award-number":["5R01 EY029223"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bcp.2021.114712","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T01:28:33Z","timestamp":1627262913000},"page":"114712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin"],"prefix":"10.1016","volume":"192","author":[{"given":"Indira","family":"Purushothaman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian S.","family":"Zagon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph W.","family":"Sassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia J.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114712_b0005","unstructured":"National Center for Chronic Disease Prevention and Health Promotion. Diabetes and prediabetes (2020) https:\/\/www.cdc.gov\/chronicdisease\/resources\/publications\/factsheets\/diabetes-prediabetes.htm."},{"key":"10.1016\/j.bcp.2021.114712_b0010","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 9th Edition 2019. https:\/\/www.diabetesatlas.org\/en\/."},{"key":"10.1016\/j.bcp.2021.114712_b0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bcp.2021.114712_b0020","unstructured":"National Center for Chronic Disease Prevention and Health Promotion (CDC). National diabetes statistics report, 2020. Estimates of diabetes and its burden in the United States. https:\/\/www.cdc.gov\/diabetes\/pdfs\/data\/statistics\/national-diabetes-statistics-report.pdf."},{"issue":"3","key":"10.1016\/j.bcp.2021.114712_b0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jtcme.2017.08.012","article-title":"An update on natural compounds in the remedy of diabetes mellitus: A systematic review","volume":"8","author":"Choudhury","year":"2018","journal-title":"J. Tradit. Complement Med."},{"key":"10.1016\/j.bcp.2021.114712_b0030","first-page":"193","article-title":"Pharmacological treatment of hyperglycemia in type 2 diabetes","volume":"1307","author":"Taylor","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bcp.2021.114712_b0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jdi.12723","article-title":"Metabolomics window into diabetic complications","volume":"9","author":"Wu","year":"2018","journal-title":"J. Diabetes Investig."},{"issue":"11","key":"10.1016\/j.bcp.2021.114712_b0040","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1007\/s00125-016-4072-7","article-title":"IRS proteins and diabetic complications","volume":"59","author":"Lavin","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2021.114712_b0045","unstructured":"American Diabetes Association. Eye complications. https:\/\/www.diabetes.org\/diabetes\/complications\/eye-complications."},{"issue":"6","key":"10.1016\/j.bcp.2021.114712_b0050","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/1753-0407.12869","article-title":"Race and sex differences in rates of diabetic complications","volume":"11","author":"Shen","year":"2019","journal-title":"J. Diabetes"},{"issue":"5","key":"10.1016\/j.bcp.2021.114712_b0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.survophthal.2020.02.005","article-title":"Diabetic keratopathy: Insights and challenges","volume":"65","author":"Priyadarsini","year":"2020","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.bcp.2021.114712_b0060","series-title":"Diabetes and Aging-Related Complications","article-title":"Diabetic eye disease","author":"Kaji","year":"2017"},{"issue":"15","key":"10.1016\/j.bcp.2021.114712_b0065","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1177\/1535370220940273","article-title":"Dysregulation of the OGF\u2013OGFr pathway correlates with elevated serum OGF and ocular surface complications in the diabetic rat","volume":"245","author":"Zagon","year":"2020","journal-title":"Exp. Biol. Med."},{"issue":"5","key":"10.1016\/j.bcp.2021.114712_b0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/1535370220972060","article-title":"Blockade of OGFr delays the onset and reduces the severity of diabetic ocular surface complications","volume":"246","author":"Zagon","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bcp.2021.114712_b0075","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3892\/etm.2021.10119","article-title":"Ocular surface complications result from dysregulation of the OGF-OGFr signaling pathway in female diabetic rats","volume":"22","author":"Purushothaman","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bcp.2021.114712_b0080","doi-asserted-by":"crossref","first-page":"113436","DOI":"10.1016\/j.physbeh.2021.113436","article-title":"Sex differences in the magnitude of diabetic ocular surface complications: Role of serum OGF","volume":"237","author":"Purushothaman","year":"2021","journal-title":"Physiol. Behav."},{"issue":"7","key":"10.1016\/j.bcp.2021.114712_b0085","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bcp.2021.114712_b0090","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4239\/wjd.v6.i6.850","article-title":"Diabetes mellitus: The epidemic of the century","volume":"6","author":"Kharroubi","year":"2015","journal-title":"World J. Diabetes"},{"issue":"10138","key":"10.1016\/j.bcp.2021.114712_b0095","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2021.114712_b0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cbi.2015.11.032","article-title":"Challenges and issues with streptozotocin-induced diabetes - A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics","volume":"244","author":"Goyal","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2021.114712_b0105","doi-asserted-by":"crossref","unstructured":"Furman BL. Streptozotocin-Induced Diabetic Models in Mice and Rats. Curr Protoc Pharmacol (2015) 70:5.47.1-5.47.20. doi:10.1002\/0471141755.ph0547s70.","DOI":"10.1002\/0471141755.ph0547s70"},{"issue":"1","key":"10.1016\/j.bcp.2021.114712_b0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1444-2892.2003.00160.x","article-title":"The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes","volume":"12","author":"Wei","year":"2003","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.bcp.2021.114712_b0115","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","article-title":"The use of animal models in diabetes research","volume":"166","author":"King","year":"2012","journal-title":"Brit J Pharmacol"},{"issue":"3","key":"10.1016\/j.bcp.2021.114712_b0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.29244\/avl.3.3.57-58","article-title":"Animal model of diabetic keratopathy","volume":"3","author":"Dewi","year":"2019","journal-title":"ARSHI Vet Lett"},{"key":"10.1016\/j.bcp.2021.114712_b0125","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1100\/tsw.2007.117","article-title":"The physiology of obese-hyperglycemic mice [ob\/ob mice]","volume":"7","author":"Lindstr\u00f6m","year":"2007","journal-title":"ScientificWorld J"},{"issue":"2","key":"10.1016\/j.bcp.2021.114712_b0130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4093\/dmj.2011.35.2.130","article-title":"Effects of spironolactone and losartan on diabetic nephropathy in a type 2 diabetic rat model","volume":"35","author":"Lee","year":"2011","journal-title":"Diabetes Metab J"},{"issue":"9","key":"10.1016\/j.bcp.2021.114712_b0135","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s00125-011-2223-4","article-title":"signs of islet microangiopathy and altered angiogenesis precede onset of type 2 diabetes in the Goto-Kakizaki (GK) rat","volume":"54","author":"Giroix","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2021.114712_b0140","doi-asserted-by":"crossref","unstructured":"Lbujimov AV. Diabetic complications in the cornea. Vision Res 2017;139:138-152. doi: 10.1016\/j.visres.2017.03.002.","DOI":"10.1016\/j.visres.2017.03.002"},{"issue":"4","key":"10.1016\/j.bcp.2021.114712_b0145","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jtos.2019.06.007","article-title":"The impact of hyperglycemia on the corneal epithelium: molecular mechanisms and insight","volume":"17","author":"Zhu","year":"2019","journal-title":"Ocul Surf"},{"issue":"11","key":"10.1016\/j.bcp.2021.114712_b0150","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.3390\/ijms19113635","article-title":"A proteomic approach for understanding the mechanisms of delayed corneal wound healing in diabetic keratopathy using diabetic model rat","volume":"19","author":"Yamamoto","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2021.114712_b0155","doi-asserted-by":"crossref","unstructured":"Del Buey MA, Casas P, Caramello C, Lopez N, de la Rica M, Subiron AB, Lanchares E, Huerva V, Grzybowski A, Ascaso FJ. An update on corneal biomechanics and architecture in diabetes. J. Ophthalmol (2019) 2019:7645352. J Ophthalmol. 2019 Jun 2;2019:7645352.","DOI":"10.1155\/2019\/7645352"},{"key":"10.1016\/j.bcp.2021.114712_b0160","first-page":"1","article-title":"Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology, and clinical characteristics","volume":"2016","author":"Zhang","year":"2016","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.bcp.2021.114712_b0165","unstructured":"Mayo Clinic. Dry eyes. www.mayoclinic.org\/diseases-conditions\/dry-eyes\/symptoms-causes."},{"issue":"2","key":"10.1016\/j.bcp.2021.114712_b0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004397-199838020-00004","article-title":"The cornea in diabetes mellitus","volume":"38","author":"S\u00e1nchez-Thorin","year":"1998","journal-title":"Int. Ophthalmol. Clin."},{"issue":"108455","key":"10.1016\/j.bcp.2021.114712_b0175","first-page":"2021","article-title":"Systemic diseases and the cornea","volume":"204","author":"Shah","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bcp.2021.114712_b0180","unstructured":"Peponis V, Bonovas S, Kapranou A, Peponi E, Filioussi K, Magkou C, Sitaras NM. Conjunctival and tear film changes after vitamin C and E administration in non-insulin dependent diabetes mellitus. Med Sci Monit (2004) 10:CR213-CR217."},{"issue":"4","key":"10.1016\/j.bcp.2021.114712_b0185","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00055735-200108000-00001","article-title":"Extracellular matrix and wound healing","volume":"12","author":"Zieske","year":"2001","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.bcp.2021.114712_b0190","first-page":"362","article-title":"Advanced glycation end products in diabetic corneas","volume":"41","author":"Kaji","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.bcp.2021.114712_b0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/joe.0.1810011","article-title":"Beta cell differentiation during early human pancreas development","volume":"181","author":"Piper","year":"2004","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bcp.2021.114712_b0200","doi-asserted-by":"crossref","unstructured":"Liu M, Weiss MA, Arunagiri A, Yong J, Rege N, Sun J, Haataja L, Kaufman RJ, Arvan P. Biosynthesis, structure, and folding of the insulin precursor protein. Diabetes, Obes Metab (2018) Suppl 2:28-50. doi:10.1111\/dom.13378.","DOI":"10.1111\/dom.13378"},{"issue":"8","key":"10.1016\/j.bcp.2021.114712_b0205","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00125-018-4639-6","article-title":"Advances in drug discovery for human beta cell regeneration","volume":"61","author":"Karakose","year":"2018","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2021.114712_b0210","first-page":"131","article-title":"The discovery and structure of human insulin","volume":"17","author":"Zimmerman","year":"2020","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.bcp.2021.114712_b0215","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3389\/fendo.2018.00748","article-title":"Sirtuins and insulin resistance","volume":"9","author":"Zhou","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"1","key":"10.1016\/j.bcp.2021.114712_b0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/nyas.14107","article-title":"Gut microbiome and its role in obesity and insulin resistance","volume":"1461","author":"Lee","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2021.114712_b0225","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s12276-020-0456-3","article-title":"Insulin receptor endocytosis in the pathophysiology of insulin resistance","volume":"52","author":"Hall","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bcp.2021.114712_b0230","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3390\/ijms20061317","article-title":"Molecular mechanisms of hypothalamic insulin resistance","volume":"20","author":"Ono","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2021.114712_b0235","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.rehab.2018.11.001","article-title":"Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"62","author":"Sampath Kumar","year":"2019","journal-title":"Ann Phys Rehabil Med."},{"key":"10.1016\/j.bcp.2021.114712_b0240","doi-asserted-by":"crossref","first-page":"T139","DOI":"10.1530\/JME-18-0016","article-title":"Role of igf-binding proteins in regulating igf responses to changes in metabolism","volume":"61","author":"Clemmons","year":"2018","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2021.114712_b0245","doi-asserted-by":"crossref","unstructured":"Trommelen J, Groen BBL, Hamer HM, De Groot LCPGM, Van Loon LJC. Mechanisms in endocrinology: Exogenous insulin does not increase muscle protein synthesis rate when administered systemically: A systematic review. Eur J Endocrinol (2015) 173:R25-R34. doi:10.1530\/EJE-14-0902.","DOI":"10.1530\/EJE-14-0902"},{"issue":"pt 2","key":"10.1016\/j.bcp.2021.114712_b0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/BST0340213","article-title":"Regulation of protein synthesis by insulin","volume":"34","author":"Proud","year":"2006","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.bcp.2021.114712_b0255","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-neuro-110719-095912","article-title":"Endogenous opioids at the intersection of opioid addiction, pain, and depression: The search for a precision medicine approach","volume":"43","author":"Emery","year":"2020","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bcp.2021.114712_b0260","series-title":"Handbook of Biologically Active Peptides","first-page":"1592","author":"McLaughlin","year":"2013"},{"issue":"1","key":"10.1016\/j.bcp.2021.114712_b0265","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10989-019-09813-7","article-title":"Opioid peptides: An overview of functional significance","volume":"26","author":"Kaur","year":"2020","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2021.114712_b0270","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0006-8993(91)91585-O","article-title":"Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system","volume":"542","author":"Zagon","year":"1991","journal-title":"Brain Res."},{"issue":"6600","key":"10.1016\/j.bcp.2021.114712_b0275","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/383535a0","article-title":"Pain responses, anxiety and aggression in mice deficient in pre- proenkephalin","volume":"383","author":"K\u00f6nig","year":"1996","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2021.114712_b0280","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1152\/physrev.00024.2017","article-title":"POMC: The physiological power of hormone processing","volume":"98","author":"Harno","year":"2018","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2021.114712_b0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0006-8993(94)01314-8","article-title":"Conserved expression of the opioid growth factor, [Met5]enkephalin, and the zeta (\u03b6) opioid receptor in vertebrate cornea","volume":"671","author":"Zagon","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2021.114712_b0290","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0165-0173(01)00160-6","article-title":"The biology of the opioid growth factor receptor (OGFr)","volume":"38","author":"Zagon","year":"2002","journal-title":"Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2021.114712_b0295","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1091\/mbc.e08-07-0681","article-title":"The OGF-OGFr axis utilizes the p16INK4a and p21WAF1\/CIP1 pathways to restrict normal cell proliferation","volume":"20","author":"Cheng","year":"2009","journal-title":"Mol. Biol. Cell"},{"issue":"3","key":"10.1016\/j.bcp.2021.114712_b0300","doi-asserted-by":"crossref","first-page":"R774","DOI":"10.1152\/ajpregu.00318.2010","article-title":"Internalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation","volume":"299","author":"Cheng","year":"2010","journal-title":"Am. J. Physiol. Reg. Integr. Comp. Physiol."},{"issue":"235","key":"10.1016\/j.bcp.2021.114712_b0305","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1258\/ebm.2010.010139","article-title":"Regulation of cell proliferation by the opioid growth factor is dependent on karyopherin \u03b2 and Ran for nucleocytoplasmic trafficking","volume":"2010","author":"Cheng","year":"2010","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bcp.2021.114712_b0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/1535370215605585","article-title":"Nuclear export of opioid growth factor receptor is CRM1 dependent","volume":"241","author":"Kren","year":"2016","journal-title":"Exp. Biol. Med."},{"issue":"9","key":"10.1016\/j.bcp.2021.114712_b0315","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0026-0495(96)90004-9","article-title":"Plasma met-enkephalin levels in diabetic patients: Influence of autonomic neuropathy","volume":"45","author":"Fallucca","year":"1996","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.bcp.2021.114712_b0320","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/09513599009030688","article-title":"High levels of circulating met-enkephalin in pregnant and menstruating type 1 diabetic women","volume":"4","author":"Negri","year":"1990","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114712_b0325","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1017\/S0952523800008580","article-title":"Ontogeny of preproenkephalin mRNA expression in the rat retina","volume":"13","author":"Isayama","year":"1996","journal-title":"Vis. Neurosci."},{"issue":"5","key":"10.1016\/j.bcp.2021.114712_b0330","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1017\/S0952523800009494","article-title":"Ontogeny of the opioid growth factor, [Met5]-enkephalin, and its binding activity in the rat retina","volume":"12","author":"Isayama","year":"1995","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.bcp.2021.114712_b0335","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2337\/diab.35.10.1143","article-title":"Altered \u03b2-endorphin, met- and leu-enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese diabetic (db\/db) mice during development of diabetic syndrome","volume":"35","author":"Timmers","year":"1986","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2021.114712_b0340","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0026-0495(90)90252-8","article-title":"Neuropeptide content in pancreas and pituitary of obese and diabetes mutant mice: Strain and sex difference","volume":"39","author":"Timmers","year":"1990","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.bcp.2021.114712_b0345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0143-4179(92)90152-M","article-title":"Effect of diabetes on the levels of two forms of met-enkephalin in plasma and peripheral tissues of the rat","volume":"21","author":"Kolta","year":"1992","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bcp.2021.114712_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/9703729","article-title":"The yin and yang of the opioid growth regulatory system: Focus on diabetes - The Lorenz E. Zimmerman tribute lecture","volume":"2016","author":"Sassani","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114712_b0355","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12020-009-9208-9","article-title":"Influence of insulin treatment on the lacrimal gland and ocular surface of diabetic rats","volume":"36","author":"M\u00f3dulo","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.bcp.2021.114712_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2019.04.014","article-title":"Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries","volume":"140","author":"Cruz-Cazarim","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bcp.2021.114712_b0365","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/ICL.0000000000000623","article-title":"Short-term results of trial of topical insulin for treatment of dry eyes in diabetics","volume":"46 Supp1 1","author":"Aniah Azmi","year":"2020","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.bcp.2021.114712_b0370","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archopht.126.4.501","article-title":"Prevention of exuberant granulation tissue and neovascularization in the rat cornea by naltrexone","volume":"126","author":"Zagon","year":"2008","journal-title":"Arch. Ophthalmol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114712_b0375","first-page":"R942","article-title":"Opioid growth factor modulates corneal epithelial outgrowth in tissue culture","volume":"268","author":"Zagon","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bcp.2021.114712_b0380","first-page":"73","article-title":"Reepithelialization of the human cornea is regulated by endogenous opioid","volume":"41","author":"Zagon","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bcp.2021.114712_b0385","first-page":"109","article-title":"Opioid growth factor receptor blockade by naltrexone as a treatment for diabetic complications","volume":"138","author":"McLaughlin","year":"2019","journal-title":"Adv. Med. Biol."},{"key":"10.1016\/j.bcp.2021.114712_b0390","first-page":"42","article-title":"Naltrexone as a novel therapeutic for diabetic corneal complications","volume":"2","author":"McLaughlin","year":"2020","journal-title":"J. Cell. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114712_b0395","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jcjd.2020.01.003","article-title":"Role of estrogen in Type 1 and Type 2 diabetes mellitus: A review of clinical and preclinical data","volume":"44","author":"De Paoli","year":"2020","journal-title":"Canad J Diabetes"},{"issue":"1","key":"10.1016\/j.bcp.2021.114712_b0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s001250051573","article-title":"Diabetes and gender","volume":"44","author":"Gale","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2021.114712_b0405","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.exer.2009.06.010","article-title":"Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type 1 diabetic rats","volume":"89","author":"Klocek","year":"2009","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114712_b0410","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2337\/diabetes.55.04.06.db05-1581","article-title":"Insulin treatment ameliorates impaired corneal re-epithelialization in diabetic rats","volume":"55","author":"Zagon","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2021.114712_b0415","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jcmgh.2018.10.016","article-title":"Resolving the paradox of hepatic ionsulin resistance","volume":"7","author":"Santoleri","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.bcp.2021.114712_b0420","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1111\/febs.12149","article-title":"Dichotomy of decorin activity on the insulin-like growth factor-I system","volume":"280","author":"Morrione","year":"2013","journal-title":"FEBS J."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:29:05Z","timestamp":1757770145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221003282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":84,"alternative-id":["S0006295221003282"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114712","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114712"}}